YAP1 and cancer: Emerging data from cancer research have also raised the possibility that the transcriptional co-activator YAP, a central mediator of the Hippo pathway, may be involved in a Hippo-independent manner (10,11), and the current understanding of the pathogenesis is that the GNAQ mutation causes excessive activation of several downstream pathways including MAPK and YAP (12).